• Fenofibrate – The main toxicity of fenofibrate is an increase in liver enzymes with occasional increases in creatine phosphokinase and, rarely
1 INDICATIONS AND USAGE FENOGLIDE is a peroxisome proliferator receptor alpha (PPARα) activator indicated as an adjunct to diet: • to reduce elevated LDL-C, Total
No relevant published information exists on the use of fenofibrate during breastfeeding
If these Ezetimibe Tablets has not been studied in Fredrickson Type I, III, IV, and V dyslipidemias
Patients should be advised to swallow fenofibrate tablets whole
Symptoms include GI distress; Treatment is supportive; Nursing mothers
1
Doses up to 160 mg q 6 hr have been administered
FDA Labeled Indications
A decision
FENOFIBRATE - fenofibrate tablet, coated Known hypersensitivity to fenofibrate (4)
2 Primary Hypercholesterolemia or Mixed Dyslipidemia 2
It is indicated to reduce total cholesterol, low-density lipoprotein (LDL), apolipoprotein B (apo B), and non-high-density lipoprotein (HDL) in patients with primary hyperlipidemia, mixed
Klebsiella species (respiratory and urinary infections)
Other Considerations: In the Coronary Drug Project, a large study of post myocardial infarction of patients treated for 5 years with clofibrate, there was no difference in mortality seen between the clofibrate group and the placebo group
INDICATIONS AND USAGE Isosorbide Dinitrate Tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease
Start at < 25 mcg/day in patients with long-standing hypothyroidism or known cardiac Fenofibric acid side effects
View the FULL Outline